Clinical Features of Mitral Regurgitation
Clinical Features of Mitral Regurgitation
Clinically, aortic regurgitation can manifest with symptoms such as awareness of heartbeat or palpitation in mild to moderate cases, and heart failure or angina in severe cases . Diagnostic assessments include ECG, which initially may be normal but later show left ventricular hypertrophy; CXR, which may reveal cardiac or aortic dilatation and features of left heart failure; echocardiography, showing a dilated left ventricle and fluttering anterior mitral leaflet; and cardiac catheterization, detecting aortic regurgitation and left ventricular dilation .
Pulmonary stenosis is characterized by symptoms and signs of right-sided heart failure and may be associated with carcinoid syndrome, featuring a giant 'a' wave in the jugular venous pulse, right ventricular hypertrophy, and an ejection systolic murmur possibly accompanied by a thrill, with a soft and delayed P2 . In contrast, pulmonary regurgitation typically presents with an early diastolic murmur (Graham Steell murmur) at the left parasternal area, often associated with pulmonary hypertension and trivial regurgitation is frequently detected by echocardiography without clinical significance .
The management of severe aortic stenosis typically involves aortic valve replacement, which is indicated when symptoms like angina, syncope, or heart failure develop . Balloon aortic valvuloplasty may be used as a palliative measure in adolescents or the elderly who are at high surgical risk .
In tricuspid stenosis, symptoms of right-sided heart failure include abdominal swelling, hepatic discomfort, peripheral edema, and fatigue, which are directly linked to impeded venous return and increased systemic venous pressure . This contrasts with other valvular conditions where right-sided heart failure symptoms might also include significant pulmonary issues due to left-sided heart failure, highlighting the isolated venous congestion typical of tricuspid stenosis.
Tricuspid regurgitation manifests with non-specific symptoms such as tiredness and edema, and specific signs like raised JVP with a large systolic c-v wave and systolic hepatic pulsation, accompanied by a pansystolic murmur louder on inspiration . Primary causes include rheumatic disease, endocarditis (commonly in intravenous drug users), and Ebstein's anomaly, while secondary causes involve right-sided dilatation due to chronic left-sided failure, right ventricular infarction, and pulmonary hypertension .
Mild to moderate pulmonary stenosis is often asymptomatic and typically requires no treatment due to its low risk for endocarditis . Severe pulmonary stenosis, defined by a gradient greater than 50 mm Hg, requires treatment with balloon valvuloplasty or surgery in rare cases .
In acute mitral regurgitation, symptoms are primarily those of acute pulmonary edema, reflecting a rapid and severe impact on hemodynamics due to the sudden incompetence of the mitral valve . In contrast, chronic mitral regurgitation presents with exertional dyspnea, nocturnal dyspnea, palpitation, and symptoms of diminished cardiac output such as fatigue, along with right heart failure symptoms such as ankle/leg edema and abdominal swelling . These differences reflect the body's adaptation over time in chronic regurgitation versus the abrupt pathophysiological changes in acute cases.
Investigative modalities for tricuspid stenosis include CXR, which shows an enlarged right atrium; echocardiography, which reveals fused thickened tricuspid valve leaflets and a dilated right atrium, with Doppler features confirming tricuspid stenosis . These investigations help in assessing the structural integrity and function of the tricuspid valve and the impact on the adjacent cardiac structures, confirming the presence and severity of the stenosis.
Vasodilators may play a preventative role in the management of aortic regurgitation by preventing progressive left ventricular dilatation, thus reducing symptoms and slowing disease progression . Surgery, specifically aortic valve replacement, becomes necessary when patients present with symptoms, progressive left ventricular dilatation, or left ventricular dysfunction, indicating that medical treatment is no longer sufficient to manage the condition .
Primary causes of mitral regurgitation include rheumatic heart disease, mitral valve prolapse, dilatation of the mitral valve ring, damage to valve cusps and ring, damage to the papillary muscle, and myocardial infarction . These conditions can lead to improper closure of the mitral valve, resulting in the backflow of blood from the left ventricle into the left atrium. This regurgitation increases the workload on the left side of the heart, leading to symptoms such as acute pulmonary edema in acute cases or exertional dyspnea, nocturnal dyspnea, and palpitation in chronic cases .